title: Pharmacokinetics of interleukin-6 during therapy with anti-interleukin-6 monoclonal antibodies: enhanced clearance of interleukin-6 by a combination of three anti-interleukin-6 antibodies.
authors.affiliation: Immunotech S.A., Marseilles, France.
authors.forename: F A
authors.initials: FA
authors.lastname: Montero-Julian
authors.forename: E
authors.initials: E
authors.lastname: Gautherot
authors.forename: J
authors.initials: J
authors.lastname: Wijdenes
authors.forename: B
authors.initials: B
authors.lastname: Klein
authors.forename: H
authors.initials: H
authors.lastname: Brailly
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006801:Humans; D015850:Interleukin-6 / Q000276:immunology / Q000493:pharmacokinetics*; D008657:Metabolic Clearance Rate / Q000276:immunology; D009101:Multiple Myeloma / Q000628:therapy*
chemical_list: D000911:Antibodies, Monoclonal; D015850:Interleukin-6